First Group of Patients in Clinical Trial With Cellect's ApoGraft Stem Cell Transplant Follow up Results 100% Acceptance and Zero Related Adverse Events Dr. Shai Yarkoni, Cellect CEO commented: "These…

Universities worldwide are looking to emulate Israel’s tech-transfer magic. By Abigail Klein Leichman It’s no coincidence that Harvard and UCLA chose experienced Israelis to direct their technology-transfer offices. Cash-strapped universities…

An innovative Israeli supplement for preventing and improving neurodegenerative diseases is here. BY JUDY SIEGEL-ITZKOVI Pomegranates are known to contain powerful antioxidants that fight the oxygen free radicals that cause…

Israeli immune based diagnostics company MeMed announced that it has been awarded a $4 million grant by the US Department of Defense's Congressionally Directed Medical Research Programs (CDMRP). The award will…

  Kai Beckmann, CEO of Performance Materials at Merck, says 'our collaboration has deep roots' as the German pharma and chemical giant expands Jerusalem lab By SHOSHANNA SOLOMON Israeli innovation…

  ALYNnovation takes medical innovations developed at the ALYN pediatric rehabilitation hospital out of the hospital so that all children can benefit from them.   Although most children on respirators…